BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

37 related articles for article (PubMed ID: 8609982)

  • 1. Identification of mutations in cystatin B, the gene responsible for the Unverricht-Lundborg type of progressive myoclonus epilepsy (EPM1).
    Lalioti MD; Mirotsou M; Buresi C; Peitsch MC; Rossier C; Ouazzani R; Baldy-Moulinier M; Bottani A; Malafosse A; Antonarakis SE
    Am J Hum Genet; 1997 Feb; 60(2):342-51. PubMed ID: 9012407
    [TBL] [Abstract][Full Text] [Related]  

  • 2. What is expanded in progressive myoclonus epilepsy?
    Lalioti MD; Scott HS; Antonarakis SE
    Nat Genet; 1997 Sep; 17(1):17. PubMed ID: 9288090
    [No Abstract]   [Full Text] [Related]  

  • 3. Progressive ataxia, myoclonic epilepsy and cerebellar apoptosis in cystatin B-deficient mice.
    Pennacchio LA; Bouley DM; Higgins KM; Scott MP; Noebels JL; Myers RM
    Nat Genet; 1998 Nov; 20(3):251-8. PubMed ID: 9806543
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene perplexes epilepsy researchers.
    O'Brien C
    Science; 1996 Mar; 271(5256):1672. PubMed ID: 8596927
    [No Abstract]   [Full Text] [Related]  

  • 5. Unstable insertion in the 5' flanking region of the cystatin B gene is the most common mutation in progressive myoclonus epilepsy type 1, EPM1.
    Lafrenière RG; Rochefort DL; Chrétien N; Rommens JM; Cochius JI; Kälviäinen R; Nousiainen U; Patry G; Farrell K; Söderfeldt B; Federico A; Hale BR; Cossio OH; Sørensen T; Pouliot MA; Kmiec T; Uldall P; Janszky J; Pranzatelli MR; Andermann F; Andermann E; Rouleau GA
    Nat Genet; 1997 Mar; 15(3):298-302. PubMed ID: 9054946
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Allelic heterogeneity of Mediterranean myoclonus and the cystatin B gene.
    Labauge P; Ouazzani R; M'Rabet A; Grid D; Genton P; Dravet C; Chkili T; Beck C; Buresi C; Baldy-Moulinier M; Malafosse A
    Ann Neurol; 1997 May; 41(5):686-9. PubMed ID: 9153533
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epilepsy. Protease inhibitor implicated.
    McNamara JO; Puranam RS
    Nature; 1996 May; 381(6577):26-7. PubMed ID: 8609982
    [No Abstract]   [Full Text] [Related]  

  • 8. Shaking down new epilepsy genes.
    Allen KM; Walsh C
    Nat Med; 1996 May; 2(5):516-8. PubMed ID: 8616704
    [No Abstract]   [Full Text] [Related]  

  • 9. Cystatins--inhibitors of cysteine proteinases.
    Bobek LA; Levine MJ
    Crit Rev Oral Biol Med; 1992; 3(4):307-32. PubMed ID: 1391414
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progressive myoclonus epilepsy of Unverricht-Lundborg type.
    Lehesjoki AE; Koskiniemi M
    Epilepsia; 1999; 40 Suppl 3():23-8. PubMed ID: 10446747
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mammalian cysteine protease inhibitors: biochemical properties and possible roles in tumor progression.
    Calkins CC; Sloane BF
    Biol Chem Hoppe Seyler; 1995 Feb; 376(2):71-80. PubMed ID: 7794528
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Towards novel anti-cancer strategies based on cystatin function.
    Keppler D
    Cancer Lett; 2006 Apr; 235(2):159-76. PubMed ID: 15893421
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.